← Leaderboards
Hugo R Rosen
Oregon Health And Science University
$16,057,795
Attributed
$18,646,507
Total exposure
22
Grants
17
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2005–21$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$26,627,461 · 22
VA$0 · 2
By mechanism
R01$10,827,164 · 7
U19$9,069,998 · 4
T32$2,275,568 · 1
U01$1,189,179 · 1
P30$1,150,345 · 1
K24$888,264 · 1
Top collaborators
- Michael J Gale5 shared
- Margaret G Petroff5 shared
- Sean P Colgan2 shared
- Veronica Wendy Setiawan1 shared
Most similar at Oregon Health And Science University
Same institution · by research overlap
- Daniel N Streblow$31,877,942
Others in their field
Top investigators on “Hepatitis C”
- Constance Ann Benson · University Of California, San Diego$171,085,251
- Sharon A Nachman · Johns Hopkins University$116,441,543
- Peter B. Gilbert · Fred Hutchinson Cancer Center$94,107,997
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$70,290,471
- Richard Douglas Moore · Johns Hopkins University$59,121,971
- Charles R Rinaldo · University Of Pittsburgh At Pittsburgh$46,122,050
Research focus
Hepatitis CHepatitis C VirusAntiviral AgentsCellsViralMediatingInfectionImmuneVirusChronic Hepatitis CT-LymphocyteResponseImmunityCohortImmune ResponseSignal TransductionInterferonsCytokineImmunotherapeutic AgentLiverPlayChronicPhenotypePathway Interactions
Grant awards (101)
Mechanisms of Advanced NAFLD Disparities in Hispanics: A Multi-level Analysis$683,885
R01 · FY2021 · MD · contact PI
Mechanisms of hepatic innate immune activation by HCV$523,114
R01 · FY2021 · AI
Innate Immunity, Cholesterol, and NASH Pathogenesis$371,250
R01 · FY2021 · DK · contact PI
Mechanisms of hepatic innate immune activation by HCV$523,114
R01 · FY2020 · AI
Restoration of immunity and function with DAA treatment in HCV infection$412,500
R01 · FY2020 · AI · contact PI
Innate Immunity, Cholesterol, and NASH Pathogenesis$371,250
R01 · FY2020 · DK · contact PI
USC Research Center for Liver Disease$1,150,345
P30 · FY2019 · DK · contact PI
Mechanisms of hepatic innate immune activation by HCV$539,963
R01 · FY2019 · AI
Restoration of immunity and function with DAA treatment in HCV infection$412,500
R01 · FY2019 · AI · contact PI
Mechanisms of hepatic innate immune activation by HCV$613,337
R01 · FY2018 · AI
Restoration of immunity and function with DAA treatment in HCV infection$363,832
R01 · FY2018 · AI · contact PI
INNATE AND ADAPTIVE IMMUNITY TO HCV IN HUMAN PREGNANCY$286,572
R01 · FY2018 · HD · contact PI
RESUBMISSION -R01 AI120622 âRestoration of Immunity and Function with DAA Treatment in HCV infection$43,343
R01 · FY2018 · AI · contact PI
Innate and Adaptive Immunity to HCV in Human Pregnancy$36,998
R01 · FY2018 · HD · contact PI
Mechanisms of hepatic innate immune activation by HCV$556,742
R01 · FY2017 · AI
RESUBMISSION -R01 AI120622 âRestoration of Immunity and Function with DAA Treatment in HCV infection$388,750
R01 · FY2017 · AI · contact PI
INNATE AND ADAPTIVE IMMUNITY TO HCV IN HUMAN PREGNANCY$321,437
R01 · FY2017 · HD · contact PI
Gastrointestinal Diseases Training Grant$145,314
T32 · FY2017 · DK · contact PI
Novel Aspects of Hepatic Innate and Adaptive Immunity to HCV Infection$0
I01 · FY2017 · VA · contact PI
INNATE AND ADAPTIVE IMMUNITY TO HCV IN HUMAN PREGNANCY$318,609
R01 · FY2016 · HD · contact PI
Gastrointestinal Diseases Training Grant$16,176
T32 · FY2016 · DK · contact PI
Novel Aspects of Hepatic Innate and Adaptive Immunity to HCV Infection$0
I01 · FY2016 · VA · contact PI
INNATE AND ADAPTIVE IMMUNITY TO HCV IN HUMAN PREGNANCY$313,134
R01 · FY2015 · HD · contact PI
Novel Aspects of Hepatic Innate and Adaptive Immunity to HCV Infection$0
I01 · FY2015 · VA · contact PI
Colorado Hepatitis C Cooperative Research Center$734,168
U19 · FY2014 · AI · contact PI
INNATE AND ADAPTIVE IMMUNITY TO HCV IN HUMAN PREGNANCY$336,028
R01 · FY2014 · HD · contact PI
Gastrointestinal Diseases Training Grant$265,693
T32 · FY2014 · DK · contact PI
Immune Escape Strategies in Hepatitis C$221,637
U19 · FY2014 · AI · contact PI
Hepatitis C viral sensing by non-parenchymal liver cells (NPC)$193,646
R21 · FY2014 · AI · contact PI
Hepatitis C Cooperative Research Center Administrative Core$59,265
U19 · FY2014 · AI · contact PI
Novel Aspects of Hepatic Innate and Adaptive Immunity to HCV Infection$0
I01 · FY2014 · VA · contact PI
Colorado Hepatitis C Cooperative Research Center$694,228
U19 · FY2013 · AI · contact PI
Gastrointestinal Diseases Training Grant$257,399
T32 · FY2013 · DK · contact PI
Immune Escape Strategies in Hepatitis C$245,764
U19 · FY2013 · AI · contact PI
Hepatitis C viral sensing by non-parenchymal liver cells (NPC)$217,728
R21 · FY2013 · AI · contact PI
Midcareer Investigator Award in Patient-Oriented Research (K24)$191,392
K24 · FY2013 · AI · contact PI
Hepatitis C Cooperative Research Center Administrative Core$51,850
U19 · FY2013 · AI · contact PI
Functional attributes of CD8+ T cells in recovery of hepatitis C virus infection$0
I01 · FY2013 · VA · contact PI
Colorado Hepatitis C Cooperative Research Center$742,779
U19 · FY2012 · AI · contact PI
HEPATITIS C VIRAL INFECTION IN HUMAN PREGNANCY$531,913
R56 · FY2012 · AI · contact PI
Immune Escape Strategies in Hepatitis C$225,083
U19 · FY2012 · AI · contact PI
Gastrointestinal Diseases Training Grant$215,933
T32 · FY2012 · DK · contact PI
Midcareer Investigator Award in Patient-Oriented Research (K24)$191,392
K24 · FY2012 · AI · contact PI
Hepatitis C Cooperative Research Center Administrative Core$58,580
U19 · FY2012 · AI · contact PI
Functional attributes of CD8+ T cells in recovery of hepatitis C virus infection$0
I01 · FY2012 · VA · contact PI
Colorado Hepatitis C Cooperative Research Center$758,229
U19 · FY2011 · AI · contact PI
Gastrointestinal Diseases Training Grant$255,617
T32 · FY2011 · DK · contact PI
Immune Escape Strategies in Hepatitis C$229,959
U19 · FY2011 · AI · contact PI
Midcareer Investigator Award in Patient-Oriented Research (K24)$191,392
K24 · FY2011 · AI · contact PI
Hepatitis C Cooperative Research Center Administrative Core$81,835
U19 · FY2011 · AI · contact PI
Functional attributes of CD8+ T cells in recovery of hepatitis C virus infection$0
I01 · FY2011 · VA · contact PI
Colorado Hepatitis C Cooperative Research Center$796,875
U19 · FY2010 · AI · contact PI
Immune Responses in Acute Hepatitis C Infection$437,726
R01 · FY2010 · DK · contact PI
Gastrointestinal Diseases Training Grant$255,861
T32 · FY2010 · DK · contact PI
Immune Escape Strategies in Hepatitis C$239,846
U19 · FY2010 · AI · contact PI
Gastrointestinal Diseases Training Grant$233,730
T32 · FY2010 · DK · contact PI
Midcareer Investigator Award in Patient-Oriented Research (K24)$191,392
K24 · FY2010 · AI · contact PI
Hepatitis C Cooperative Research Center Administrative Core$89,843
U19 · FY2010 · AI · contact PI
Immune Escape Strategies in HCV infection$603,441
U19 · FY2009 · AI · contact PI
Immune Responses in Acute Hepatitis C Infection$465,410
R01 · FY2009 · DK · contact PI
Innate Immune Responses During Therapy for Chronic HCV$270,459
R01 · FY2009 · DK · contact PI
Gastrointestinal Diseases Training Grant$204,370
T32 · FY2009 · DK · contact PI
Innate and Regulatory Immune Responses in Acute HCV$143,386
U19 · FY2009 · AI · contact PI
Midcareer Investigator Award in Patient-Oriented Research (K24)$122,696
K24 · FY2009 · AI · contact PI
Functional attributes of CD8+ T cells in recovery of hepatitis C virus infection$0
I01 · FY2009 · VA · contact PI
Immune Escape Strategies in HCV infection$603,441
U19 · FY2008 · AI · contact PI
Innate Immune Responses During Therapy for Chronic HCV$270,459
R01 · FY2008 · DK · contact PI
Gastrointestinal Diseases Training Grant$185,100
T32 · FY2008 · DK · contact PI
Innate and Regulatory Immune Responses in Acute HCV$143,390
U19 · FY2008 · AI · contact PI
IMMUNE RESPONSES IN ACUTE HEPATITIS C INFECTION$198
M01 · FY2008 · RR · contact PI
Immune Escape Strategies in HCV infection$613,947
U19 · FY2007 · AI · contact PI
Innate Immune Responses During Therapy for Chronic HCV$275,979
R01 · FY2007 · DK · contact PI
Gastrointestinal Diseases Training Grant$240,375
T32 · FY2007 · DK · contact PI
Innate and Regulatory Immune Responses in Acute HCV$153,859
U19 · FY2007 · AI · contact PI
IMMUNE RESPONSES IN ACUTE HEPATITIS C INFECTION$1,683
M01 · FY2007 · RR · contact PI
Immune Escape Strategies in HCV infection$633,502
U19 · FY2006 · AI · contact PI
Innate Immune Responses During Therapy for Chronic HCV$284,221
R01 · FY2006 · DK · contact PI
Innate and Regulatory Immune Responses in Acute HCV$147,512
U19 · FY2006 · AI · contact PI
Innate Immune Responses During Therapy for Chronic HCV$38,500
R01 · FY2006 · DK · contact PI
Immune Escape Strategies in HCV infection$649,999
U19 · FY2005 · AI
Innate Immune Responses During Therapy for Chronic HCV$252,560
R01 · FY2005 · DK
Immune Responses in Acute Hepatitis C Infection$152,458
R01 · FY2005 · DK
Innate and Regulatory Immune Responses in Acute HCV$147,580
U19 · FY2005 · AI
Immune Responses in Acute Hepatitis C Infection$117,457
R01 · FY2005 · DK
Immune Responses in Acute Hepatitis C Infection$50,400
R01 · FY2005 · DK
Cellular Immune Mechanisms of Resistance to HCV Therapy$33,083
U01 · FY2005 · DK
DENDRITIC CELLS IN HEPATITIS C VIRUS INFECTED AND UNINFECTED INDIVIDUALS$17,410
M01 · FY2005 · RR
Cellular Immune Mechanisms of Resistance to HCV Therapy$16,914
U01 · FY2005 · DK
ANALYSIS OF ACUTE HEPATITIS C OUTCOMES AND RISK FACTORS$16,789
M01 · FY2005 · RR
Cellular Immune Mechanisms of Resistance to HCV Therapy$275,000
U01 · FY2004 · DK
Immune Responses in Acute Hepatitis C Infection$269,915
R01 · FY2004 · DK
Dendritic Cells in Hepatitis C Virus Infected and Uninfected Individuals$51,943
M01 · FY2004 · RR
Analysis of Acute Hepatitis C Outcomes and Risk Factors$23,222
M01 · FY2004 · RR
Cellular Immune Mechanisms of Resistance to HCV Therapy$270,000
U01 · FY2003 · DK
Immune Responses in Acute Hepatitis C Infection$269,915
R01 · FY2003 · DK
Cellular Immune Mechanisms of Resistance to HCV Therapy$475,000
U01 · FY2002 · DK
Immune Responses in Acute Hepatitis C Infection$255,347
R01 · FY2002 · DK
INTRON A + RIBAVIRIN FOR TREATMENT OF CHRONIC HEPATITIS$172,411
M01 · FY2001 · RR
Cellular Immune Mechanisms of Resistance to HCV Therapy$119,182
U01 · FY2001 · DK
INTRON A + RIBAVIRIN FOR TREATMENT OF CHRONIC HEPATITIS$0
M01 · FY2001 · RR
INTRON A + RIBAVIRIN FOR TREATMENT OF CHRONIC HEPATITIS$0
M01 · FY2000 · RR